🌍 Africa’s Top Exports
This is a resource continent
🛢 Oil across West and North Africa
🥇 Gold across the Sahel and East Africa
🔋 Copper & cobalt in DRC and Zambia
⚛️ Uranium in Niger & Namibia
💎 Diamonds in Botswana & South Africa
Agriculture shows up. Coffee, cocoa, cotton.
But hard #commodities drive FX.
This matters for global markets.
#Energy transition needs #copper, cobalt, uranium.
Food markets depend on African output.
Oil flows shape Atlantic Basin pricing.
Africa isn’t peripheral.
It’s embedded in every major commodity chain.
The question isn’t resources.
It’s who captures value beyond extraction.
This is a resource continent
🛢 Oil across West and North Africa
🥇 Gold across the Sahel and East Africa
🔋 Copper & cobalt in DRC and Zambia
⚛️ Uranium in Niger & Namibia
💎 Diamonds in Botswana & South Africa
Agriculture shows up. Coffee, cocoa, cotton.
But hard #commodities drive FX.
This matters for global markets.
#Energy transition needs #copper, cobalt, uranium.
Food markets depend on African output.
Oil flows shape Atlantic Basin pricing.
Africa isn’t peripheral.
It’s embedded in every major commodity chain.
The question isn’t resources.
It’s who captures value beyond extraction.
This media is not supported in your browser
VIEW IN TELEGRAM
$DELL $ARM $UBER $CRM $HOOD $NOW | Trump Accounts offer newborns a $1,000 federal seed and a $250 Dell bonus for mid income ZIPs.
With a $5K annual limit and tax deferred growth, these accounts can scale from $271K at age 18 to over $2M by retirement.
With a $5K annual limit and tax deferred growth, these accounts can scale from $271K at age 18 to over $2M by retirement.
🇨🇭 Global One SI - Prompt
$ASTI $RKLB $ASTS $LUNR $RDW $VOYG | Elon Musk outlines "Moonbase Alpha," a plan to launch AI satellites via a lunar mass driver. "I really want to see a mass driver on the Moon shooting AI satellites into deep space, and ultimately visiting the stars."
$ASTI $RKLB $ASTS $LUNR $RDW $VOYG | Elon Musk: "If aircraft were single use, air travel would be prohibitively expensive. Fully reusable rockets could reduce spaceflight costs by a factor of 100."
SpaceX aims for full reusability in 2026 to drop LEO costs to under $100/lb.
SpaceX aims for full reusability in 2026 to drop LEO costs to under $100/lb.
🇨🇭 Global One SI - Prompt
$IREN $CLSK $CIFR $BITF $WULF $CRWV | Sam Altman on energy as AI’s limiting factor: "Eventually the cost of AI will converge to the cost of energy. In terms of strategic investments for the U.S., I can’t think of anything more important than energy."
$EOSE $VST $BE $CEG $VRT $IREN $CIFR | Global power demand is growing 3.6% annually through 2030. In this "Age of Electricity," the IEA warns that grids are the weakest link.
With 2,500GW of projects stalled, annual investment must jump 50% to $600B to keep up with the surge.
With 2,500GW of projects stalled, annual investment must jump 50% to $600B to keep up with the surge.
The US has accepted Iran’s proposal to maintain #uranium enrichment.
This does not reduce the immediate risk of a US/Israel strike on Iran.
Trump has shown that he is willing to take military action even during negotiations.
Therefore, US acceptance of Iran’s uranium enrichment capacity does not eliminate the risk.
The US has moved significant military assets to the Middle East... not simply to accept Iran’s proposal and withdraw them.
This does not reduce the immediate risk of a US/Israel strike on Iran.
Trump has shown that he is willing to take military action even during negotiations.
Therefore, US acceptance of Iran’s uranium enrichment capacity does not eliminate the risk.
The US has moved significant military assets to the Middle East... not simply to accept Iran’s proposal and withdraw them.
This media is not supported in your browser
VIEW IN TELEGRAM
LRASM (Long Range Anti-Ship Missile) 🇺🇸 with autonomous target detection, identification & engagement for contested maritime environments.$LMT
⚡1
Media is too big
VIEW IN TELEGRAM
Underwater Warfare unveiled: New stealthy autonomous underwater drone 'Lamprey MMAUV' by Lockheed Martin 🇺🇸. $LMT
⚡1
This media is not supported in your browser
VIEW IN TELEGRAM
This guy tested #Starlink in the middle of the ocean and played CS2 with almost perfect ping
🇨🇭 Global One SI - Prompt
What If the U.S. absorbed Canada, Mexico, and Greenland?
BREAKING: Mexico has erupted into chaos as a joint op between the U.S. & Mexican army has killed the largest drug lord El Mencho.
All Americans across Mexico are ordered to shelter in place as the cartel has taken over airports & is setting fires across the country.
All Americans across Mexico are ordered to shelter in place as the cartel has taken over airports & is setting fires across the country.
🔥1
🇨🇭 Global One SI - Prompt
Video
Media is too big
VIEW IN TELEGRAM
Report from Ground Zero in Mexico, as Cartel Forces attack Mexican military forces and Police across the country now. Cartels are attacking civilian targets, airports, hospitals, grocery stores. President Trump must begin destroying the Cartels directly!!
👀1
$INFQ - NEW QUANTUM LEADER 🔥
As the first neutral-atom quantum company to go public, with strong government traction and a differentiated tech stack.
I see a clear path to 300%+ upside from these levels.
Price target: $13 → $52 📈
Most investors see Infleqtion as just another early-stage quantum hardware bet.High risk, long timelines, capex heavy.
They’re missing the forest for the atoms: Infleqtion isn’t purely a quantum computer builder; it’s a full-stack provider of neutral-atom quantum computing, networking, sensing, and software, delivering practical solutions today.
Here’s the bull thesis for $INFQ, grounded in recent filings, announcements, and commercial momentum.
Scalable One-to-Many Economics:
Neutral-atom tech stands out for room-temperature operation, scalability, and lower costs vs. superconducting or trapped-ion rivals.
Build once, deploy across computing and sensing: One platform serves infinite users via cloud/hybrid access. Sensors (clocks, navigation, RF) generate revenue now, while computing ramps.
Revenue has grown 80% YoY recently, with booked/awarded deals at $50M multi-year value and a $300M+ pipeline, pointing to software-like margin expansion as scale hits.
Unreplicable Moat:
Neutral-Atom Leadership & Dual-Use Tech Competitors chase qubit counts; Infleqtion leverages Nobel-winning neutral-atom physics for both high-fidelity computing and ultra-precise sensing.
Hundreds of patents, 130+ PhDs, systems already deployed with DoD, NASA, UK gov, and NVIDIA collaborations.
Barrier: Retroactively building 19+ years of cold-atom expertise and dual quantum-compute + sensing stack is near-impossible.
This positions $INFQ for AI acceleration, secure comms, navigation, and grid optimization.
Financial Strength
Fresh off $550M+ raise via SPAC merger (Feb 2026), well-capitalized with minimal dilution risk.
No desperate cash burn like some peer, government/defense contracts provide sticky, non-dilutive funding (e.g., ARPA-E $6.2M, Army deals).
High-Quality, Sticky Revenue Heavy government focus (DoD, NASA, allies) means recurring, mission-critical contracts, once embedded in defense/aerospace workflows, low churn.
Pipeline includes energy grid, navigation, and timing, turning quantum into “utility” revenue.
Government & Geopolitical Tailwinds:
Quantum is a national security priority amid US-China race. Infleqtion’s neutral-atom edge and existing DoD/NASA embeds position it for inelastic demand in sensing and computing.
Recent catalysts: ARPA-E grid project, Army ML navigation contract, NVIDIA pubs.
Valuation Disconnect Market caps $INFQ $550-800M range post-debut, treating it like speculative de-SPAC.
But with real revenue, monopoly in neutral-atom, fortress balance sheet post-raise, and dual compute/sensing moat, it’s undervalued vs. peers.
Catalyst: Roadmap to 100+ logical qubits by 2028, more gov wins, sensing revenue acceleration, potential partnerships.
Summary ✍️
You’re buying the leader in scalable, dual-use neutral-atom quantum at cash-plus-premium levels.
As the first neutral-atom quantum company to go public, with strong government traction and a differentiated tech stack.
I see a clear path to 300%+ upside from these levels.
Price target: $13 → $52 📈
Most investors see Infleqtion as just another early-stage quantum hardware bet.High risk, long timelines, capex heavy.
They’re missing the forest for the atoms: Infleqtion isn’t purely a quantum computer builder; it’s a full-stack provider of neutral-atom quantum computing, networking, sensing, and software, delivering practical solutions today.
Here’s the bull thesis for $INFQ, grounded in recent filings, announcements, and commercial momentum.
Scalable One-to-Many Economics:
Neutral-atom tech stands out for room-temperature operation, scalability, and lower costs vs. superconducting or trapped-ion rivals.
Build once, deploy across computing and sensing: One platform serves infinite users via cloud/hybrid access. Sensors (clocks, navigation, RF) generate revenue now, while computing ramps.
Revenue has grown 80% YoY recently, with booked/awarded deals at $50M multi-year value and a $300M+ pipeline, pointing to software-like margin expansion as scale hits.
Unreplicable Moat:
Neutral-Atom Leadership & Dual-Use Tech Competitors chase qubit counts; Infleqtion leverages Nobel-winning neutral-atom physics for both high-fidelity computing and ultra-precise sensing.
Hundreds of patents, 130+ PhDs, systems already deployed with DoD, NASA, UK gov, and NVIDIA collaborations.
Barrier: Retroactively building 19+ years of cold-atom expertise and dual quantum-compute + sensing stack is near-impossible.
This positions $INFQ for AI acceleration, secure comms, navigation, and grid optimization.
Financial Strength
Fresh off $550M+ raise via SPAC merger (Feb 2026), well-capitalized with minimal dilution risk.
No desperate cash burn like some peer, government/defense contracts provide sticky, non-dilutive funding (e.g., ARPA-E $6.2M, Army deals).
High-Quality, Sticky Revenue Heavy government focus (DoD, NASA, allies) means recurring, mission-critical contracts, once embedded in defense/aerospace workflows, low churn.
Pipeline includes energy grid, navigation, and timing, turning quantum into “utility” revenue.
Government & Geopolitical Tailwinds:
Quantum is a national security priority amid US-China race. Infleqtion’s neutral-atom edge and existing DoD/NASA embeds position it for inelastic demand in sensing and computing.
Recent catalysts: ARPA-E grid project, Army ML navigation contract, NVIDIA pubs.
Valuation Disconnect Market caps $INFQ $550-800M range post-debut, treating it like speculative de-SPAC.
But with real revenue, monopoly in neutral-atom, fortress balance sheet post-raise, and dual compute/sensing moat, it’s undervalued vs. peers.
Catalyst: Roadmap to 100+ logical qubits by 2028, more gov wins, sensing revenue acceleration, potential partnerships.
Summary ✍️
You’re buying the leader in scalable, dual-use neutral-atom quantum at cash-plus-premium levels.
🇨🇭 Global One SI - Prompt
Photo
No doubt that $INFQ will become the BIGGEST and MOST SUCCESSFUL quantum company of ALL TIME 🔥
• NVIDIA
• Voyager Technologies
• Oak Ridge National Laboratory
• NASA
• U.S. Department of Energy
• U.S. Army
• U.S. Department of War
• U.K. Government
• NVIDIA
• Voyager Technologies
• Oak Ridge National Laboratory
• NASA
• U.S. Department of Energy
• U.S. Army
• U.S. Department of War
• U.K. Government
These 3 hidden gems are about to ignite - $ONDS $IBRX $INFQ 🔥
The market’s sleeping on massive momentum right now, but the contracts, approvals, cash piles, and guidance are screaming explosive upside.
These aren’t hype plays – they’re backed by real deals, regulatory wins, and billion-dollar tailwinds in defense, biotech, and quantum tech.
Here’s why smart money is loading up:
$ONDS – The emerging defense powerhouse in autonomous systems.
Just locked in game-changing contracts:
German State Police for airspace protection, multi-million Euro order for Iron Drone Raider after successful airport deployment, fresh Asia-Pacific defense win, and a $30M+ multi-year demining program in Israel.
Backlog exploding, Blue UAS cleared, and acquisitions stacking up (like Rotron Aero for next-gen attack capabilities). They just crushed it with raised 2026 revenue guidance. Over $1.5B cash. From R&D to global prime contractor status – this is the breakout story in drone dominance!
$IBRX – Turning cancer treatment on its head with ANKTIVA
Massive global expansion:
European Commission approval unlocking 33 countries for bladder cancer, new distribution partnerships across the EU (Irish subsidiary live), and fresh launch deal in Saudi Arabia + MENA for bladder AND lung cancer. SFDA nods accelerating access in huge markets.
Revenue already surging hard from commercial traction, pipeline heating up with CAR-NK therapies, glioblastoma data showing unreal survival signals, and outpatient/chemo-free edge that’s changing oncology forever.
From early-stage biotech to real-world blockbuster potential – billions in addressable market waiting to be captured.
$INFQ – The first neutral atom quantum pure play now public on NYSE.
Just went live via SPAC with over $550 MILLION in fresh capital – massive war chest to scale.
Neutral-atom tech leading the pack: high-fidelity qubits, precision sensing, NASA missions, US Army contracts, NVIDIA collabs, and a clear roadmap to commercially viable quantum computers by 2028.
CEO dropping truth bombs: US must win the quantum race and Infleqtion is positioned at the forefront.
This is the early NVIDIA of quantum, explosive potential in computing, sensing, and national security.
These aren’t lottery tickets, they’re companies executing with contracts, cash, approvals, and guidance that point to massive rerating ahead.
Defense boom, biotech globalization, quantum supremacy, all accelerating under the current macro.
Which stock do you prefer? 🤔
DYOR.
The market’s sleeping on massive momentum right now, but the contracts, approvals, cash piles, and guidance are screaming explosive upside.
These aren’t hype plays – they’re backed by real deals, regulatory wins, and billion-dollar tailwinds in defense, biotech, and quantum tech.
Here’s why smart money is loading up:
$ONDS – The emerging defense powerhouse in autonomous systems.
Just locked in game-changing contracts:
German State Police for airspace protection, multi-million Euro order for Iron Drone Raider after successful airport deployment, fresh Asia-Pacific defense win, and a $30M+ multi-year demining program in Israel.
Backlog exploding, Blue UAS cleared, and acquisitions stacking up (like Rotron Aero for next-gen attack capabilities). They just crushed it with raised 2026 revenue guidance. Over $1.5B cash. From R&D to global prime contractor status – this is the breakout story in drone dominance!
$IBRX – Turning cancer treatment on its head with ANKTIVA
Massive global expansion:
European Commission approval unlocking 33 countries for bladder cancer, new distribution partnerships across the EU (Irish subsidiary live), and fresh launch deal in Saudi Arabia + MENA for bladder AND lung cancer. SFDA nods accelerating access in huge markets.
Revenue already surging hard from commercial traction, pipeline heating up with CAR-NK therapies, glioblastoma data showing unreal survival signals, and outpatient/chemo-free edge that’s changing oncology forever.
From early-stage biotech to real-world blockbuster potential – billions in addressable market waiting to be captured.
$INFQ – The first neutral atom quantum pure play now public on NYSE.
Just went live via SPAC with over $550 MILLION in fresh capital – massive war chest to scale.
Neutral-atom tech leading the pack: high-fidelity qubits, precision sensing, NASA missions, US Army contracts, NVIDIA collabs, and a clear roadmap to commercially viable quantum computers by 2028.
CEO dropping truth bombs: US must win the quantum race and Infleqtion is positioned at the forefront.
This is the early NVIDIA of quantum, explosive potential in computing, sensing, and national security.
These aren’t lottery tickets, they’re companies executing with contracts, cash, approvals, and guidance that point to massive rerating ahead.
Defense boom, biotech globalization, quantum supremacy, all accelerating under the current macro.
Which stock do you prefer? 🤔
DYOR.
✍1
🇨🇭 Global One SI - Prompt
$IBRX is ready to explode ANKTIVA just got EU approval -> 33 countries unlocked, first immunotherapy for tough bladder cancer there. US sales exploded 700% YoY to $113M in 2025 - and that's just ONE market. Saudi approval for lung cancer + more indications…
This media is not supported in your browser
VIEW IN TELEGRAM
Dr. Patrick Soon-Shiong revealed a game-changing cancer breakthrough on Sean Spicer’s show: “We’ve built the world’s first AI-driven robotic factory that turns a pint of your blood into billions of activated natural killer cells — frozen, ready to infuse in 30 minutes as an outpatient.”
Key points from the 2:26 clip:
- IL-15 jab supercharges your body to grow NK cells (NCI calls it the most important molecule to cure cancer).
- Blood draw → robot grows trillions of targeted NK cells → freeze into doses anyone can receive (like type O blood).
- The humanoid robot + AI vision system slashes production cost 10×.
- First full-scale unit installs in Los Angeles in ~3 months, second ships to Saudi Arabia.
- Goal: become the “American Red Cross of cancer” — mass-produced, affordable NK therapy for the world.
Sean Spicer: “It’s embarrassing as an American that we had this first… and the Saudis are going to bring it to market in a much better way.”
A potential revolution in cancer treatment — off-the-shelf, engineered NK cells made at scale.
What do you think — is this the future of cancer care, or too good to be true? $IBRX
Key points from the 2:26 clip:
- IL-15 jab supercharges your body to grow NK cells (NCI calls it the most important molecule to cure cancer).
- Blood draw → robot grows trillions of targeted NK cells → freeze into doses anyone can receive (like type O blood).
- The humanoid robot + AI vision system slashes production cost 10×.
- First full-scale unit installs in Los Angeles in ~3 months, second ships to Saudi Arabia.
- Goal: become the “American Red Cross of cancer” — mass-produced, affordable NK therapy for the world.
Sean Spicer: “It’s embarrassing as an American that we had this first… and the Saudis are going to bring it to market in a much better way.”
A potential revolution in cancer treatment — off-the-shelf, engineered NK cells made at scale.
What do you think — is this the future of cancer care, or too good to be true? $IBRX